Description

N'-(7-[1-(3-Fluorophenoxy)Ethyl][1,2,4]Triazolo[1,5-A]Pyrimidin-2-Yl)-N,n-Dimethyliminoformamide is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of novel active ingredients. This compound is valued for its role as a key building block in medicinal chemistry, enabling the development of targeted therapeutic agents. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the discovery and production of new drugs, particularly in areas requiring complex heterocyclic scaffolds.

Application

• Pharmaceutical Intermediate: A critical precursor in the synthesis of novel drug candidates, particularly those targeting specific enzymatic pathways.
• Agrochemical Research: Used in the development of new pesticides and herbicides, leveraging its triazolopyrimidine core structure for biological activity.
• Chemical Biology Probes: Serves as a scaffold for creating molecular probes to study biological processes and protein interactions in R&D settings.
• Organic Synthesis Building Block: Employed in academic and industrial laboratories for constructing complex heterocyclic compounds for material science and catalysis research.

Basic Information

Product Name	N'-(7-[1-(3-Fluorophenoxy)Ethyl][1,2,4]Triazolo[1,5-A]Pyrimidin-2-Yl)-N,n-Dimethyliminoformamide
CAS No.	477865-41-1
Molecular Formula	C₁₈H₁₉FN₆O₂
Molecular Weight	370.38 g/mol
Synonyms	N'-(7-[1-(3-Fluorophenoxy)ethyl][1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N,N-dimethylformimidamide; N,N-Dimethyl-N'-[7-[1-(3-fluorophenoxy)ethyl][1,2,4]triazolo[1,5-a]pyrimidin-2-yl]formimidamide; 477865-41-1; Formimidamide, N,N-dimethyl-N'-[7-[1-(3-fluorophenoxy)ethyl][1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-; [1,2,4]Triazolo[1,5-a]pyrimidine-2-carboximidamide derivative
EINECS	Contact for details

Quality Control

Our production of N'-(7-[1-(3-Fluorophenoxy)Ethyl][1,2,4]Triazolo[1,5-A]Pyrimidin-2-Yl)-N,n-Dimethyliminoformamide adheres to stringent quality management protocols. Every batch undergoes comprehensive analytical testing, including HPLC for purity and NMR for structural confirmation, to ensure it meets the exacting standards required for pharmaceutical R&D. Certificates of Analysis (COA) detailing all specifications are provided and can be tailored to meet specific client or regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep the container sealed to protect this light-sensitive material from moisture and atmospheric contaminants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.